The "Peripheral Access Utilizing Sonographic Evaluation" Study
NCT ID: NCT02360163
Last Updated: 2018-08-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2015-02-28
2017-01-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ultrasound-guided Peripheral IJ Study
NCT03231345
Superior Venous Access, Midline vs Ultrasound IVs
NCT03440944
Ultrasound-guided Peripheral Intravenous Catheter Insertion Technique
NCT04218643
Comparison of Ultrasound Guided Peripheral IV Placement With and Without Use of a Guidewire
NCT02422472
Ultrasound Guided Vascular Access in Pediatric Intensive Care Patients
NCT00207883
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The ultrasound assisted technique will increase accessibility to small veins that might be missed via the manual technique. The technique of using an ultrasound machine to assist the administration of fluids into a patient's veins is called ultrasound guided peripheral intravenous access (USGPIVA), while the traditional technique that uses only sight and touch to locate a patient veins without machine assistance is called the traditional landmark technique (TLT). The investigators will compare the effectiveness of USGPIVA with TLT in terms of reducing complications and costs.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Landmark Technique Attempt
Patients will undergo an additonal TLT attempt
Traditional Landmark Technique (TLT)
USGPIVA Technique Attempt
Patients will be offered a USGPIVA attempt after two failed attempts using the traditional landmark technique (TLT)
ultrasound guided peripheral intravenous access (USGPIVA)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Traditional Landmark Technique (TLT)
ultrasound guided peripheral intravenous access (USGPIVA)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Adult critically ill patients in CCU and MICU requiring short peripheral intravenous access
* The patient has been identified as difficult intravenous access (DIVA), defined as at least two failed blind sticks in the antecubital fossa or more distal upper arm veins
* The patient does not otherwise require a CVC
Exclusion Criteria
* Has a condition poses risk for DIC, inadequate flow, or infection.
* Has been identified as a site for "Save the Vein" protocol implementation, unless permission is otherwise obtained by the patient's physician.
* Has a hemodialysis fistula in place on that upper arm side.
* The patient is expected to require therapeutic agent or procedure that necessitates central venous access such as:
* central venous monitoring
* Total Parenteral Nutrition
* Antibiotic requiring central venous access
* Chemotherapy
* Vesicants
* Medications pH less than 5 or more than 9
* Medications of glucose concentrations above 10%
* Solution with protein concentrations above 5% (Vascular Access Management, n.d.)
* The patient already has a central venous catheter access, for reasons other than DIVA, through which therapy can be infused
* The patient has renal disease and a "Save The Vein" order is anticipated or pending (serum creatinine \>2mg/dL and GFR \<20) for one of the patient's arms, unless permission is otherwise obtained by the patient's physician
* The patient has a bleeding disorder, unless permission is otherwise obtained by the patient's physician
* The clinician believes the patient is not a good fit for the study or that the procedure is not appropriate for patient at the given moment
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hackensack Meridian Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nancy Van Buitenen, MSN, APN, RN
Role: PRINCIPAL_INVESTIGATOR
Hackensack UMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hackensack University Medical center
Hackensack, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Tada M, Yamada N, Matsumoto T, Takeda C, Furukawa TA, Watanabe N. Ultrasound guidance versus landmark method for peripheral venous cannulation in adults. Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD013434. doi: 10.1002/14651858.CD013434.pub2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro 2921
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.